Cargando…

Characterization of the Interaction of TZT‐1027, a Potent Antitumor Agent, with Tubulin

TZT‐1027, a derivative of dolastatin 10 isolated from the Indian Ocean sea hare Dolabella auricularia in 1987 by Pettit et al., is a potent antimicrotubule agent. We have compared the activity of TZT‐1027 with that of dolastatin 10 as well as the vinca alkaloids vinblastine (VLB), vincristine (VCR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natsume, Tsugitaka, Watanabe, Jun‐ichi, Tamaoki, Satoru, Fujio, Nami, Miyasaka, Katsuhiko, Kobayashi, Motohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2000
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926414/ https://www.ncbi.nlm.nih.gov/pubmed/10920282 http://dx.doi.org/10.1111/j.1349-7006.2000.tb01007.x

Ejemplares similares

Antitumor Activity of TZT‐1027, a Novel Doiastatin 10 Derivative
por: Kobayashi, Motohiro, et al.
Publicado: (1997)

TZT‐1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death
por: Otani, Masashi, et al.
Publicado: (2000)

Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents
por: Yan, Qi, et al.
Publicado: (2016)

The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
por: Akashi, Y, et al.
Publicado: (2007)

Manipulation of pathway regulation in Streptomyces globisporus for overproduction of the enediyne antitumor antibiotic C-1027
por: Chen, Yihua, et al.
Publicado: (2010)

Role of sgcR3 in positive regulation of enediyne antibiotic C-1027 production of Streptomyces globisporus C-1027
por: Wang, Lifei, et al.
Publicado: (2009)

Complications of post-cochlear implantation in 1027 adults and children
por: Halawani, Roa, et al.
Publicado: (2019)

Complete genome assembly and characterization of an outbreak strain of the causative agent of swine erysipelas – Erysipelothrix rhusiopathiae SY1027
por: Kwok, Amy HY, et al.
Publicado: (2014)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
por: Niu, Zhenxi, et al.
Publicado: (2022)

Análisis de procedimiento para restablecer la subarea de control PR-TZT en caso de colapso total /
por: Carballo López, Marco Antonio
Publicado: (2002)

Crystal Structure of SgcJ, An NTF2-Like Superfamily Protein Involved in Biosynthesis of the 9-Membered Enediyne Antitumor Antibiotic C-1027
por: Huang, Tingting, et al.
Publicado: (2016)

The 1027(th) target candidate in stroke: Will NADPH oxidase hold up?
por: Radermacher, Kim A, et al.
Publicado: (2012)

1027. Vancomycin Use in Community-Acquired Pneumonia: Assessing Inappropriate Therapy
por: Shan, Timothy, et al.
Publicado: (2019)

Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
por: Liu, Wei, et al.
Publicado: (2023)

The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization
por: Ihmaid, Saleh, et al.
Publicado: (2018)

Drug repurposing: Discovery of troxipide analogs as potent antitumor agents
por: Lu, Nan, et al.
Publicado: (2020)

Verification measurements of the IRMM-1027 and the IAEA large-sized dried (LSD) spikes
por: Jakopič, R., et al.
Publicado: (2016)

Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples
por: Yuan, Feng, et al.
Publicado: (2019)

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
por: Majcher, Urszula, et al.
Publicado: (2018)

1027. Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs): Is It Safe?
por: Rizvi, Hira, et al.
Publicado: (2018)

Computational Prediction of the Mode of Binding of Antitumor Lankacidin C to Tubulin
por: Ayoub, Ahmed Taha, et al.
Publicado: (2019)

Antivascular and antitumor properties of the tubulin-binding chalcone TUB091
por: Canela, María-Dolores, et al.
Publicado: (2016)

Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
por: Xu, Qifu, et al.
Publicado: (2020)

Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect
por: Yang, Jianhong, et al.
Publicado: (2021)

Interaction of the novel agent amphethinile with tubulin.
por: McGown, A. T., et al.
Publicado: (1989)

Asthma diagnosis and treatment - 1027. Body mass index of asthmatic children in United Arab Emirates
por: Al-Hammadi, Suleiman, et al.
Publicado: (2013)

DNMTs inhibitor SGI-1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells
por: Sun, Ning, et al.
Publicado: (2018)

Causes of brain dysfunction in acute coma: a cohort study of 1027 patients in the emergency department
por: Schmidt, Wolf Ulrich, et al.
Publicado: (2019)

1027. At-Home vs. In-Clinic Receipt of Cabotegravir and Rilpivirine Long-Acting: An Implementation Science Trial
por: Williams, Jamila K, et al.
Publicado: (2023)

Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition
por: Xu, Shaohua, et al.
Publicado: (2021)

A review of research progress of antitumor drugs based on tubulin targets
por: Cheng, Ziqi, et al.
Publicado: (2020)

Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors
por: Yang, Wei, et al.
Publicado: (2022)

Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site
por: Fu, Dong-Jun, et al.
Publicado: (2017)

Rational Design, Synthesis, and Biological Evaluation of Third Generation α-Noscapine Analogues as Potent Tubulin Binding Anti-Cancer Agents
por: Manchukonda, Naresh Kumar, et al.
Publicado: (2013)

1027. Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants
por: Towner, William, et al.
Publicado: (2020)

SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care
por: Koh, Sky Wei Chee, et al.
Publicado: (2023)

Tubulin-interactive stilbene derivatives as anticancer agents
por: Mikstacka, Renata, et al.
Publicado: (2013)

A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers
por: Liu, Zi, et al.
Publicado: (2022)

Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
por: Naoe, Yoshinori, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_18ljp9bn4ol87jug0agevjas2n